I Had a Lupus-Like Reaction on Penicillamine — Do I Have to Switch Forever?

A lupus-like reaction — joint pain, skin rash (sometimes following the cheekbones), fever, fatigue, and positive antinuclear antibodies (ANA) — is one of the more serious immune reactions that penicillamine can trigger, and it is qualitatively different from the milder hypersensitivity reactions that sometimes appear in the first few weeks of treatment. If your specialist has confirmed this is what you have, it raises two questions that matter enormously: do you need to stop permanently, and is restarting ever an option?

What a lupus-like reaction actually means

Penicillamine is one of a handful of medications well documented to cause drug-induced lupus (DIL) — a condition that resembles systemic lupus erythematosus (SLE) but is caused by the drug rather than the underlying autoimmune process.¹ In the context of penicillamine, the reaction has been described in patients being treated for both rheumatoid arthritis (where it was historically widely used) and Wilson disease.

The defining features that distinguish this from milder early reactions:

• Positive ANA (antinuclear antibodies), sometimes in high titre
• Clinical features resembling lupus: malar rash, polyarthritis, serositis (pleuritis or pericarditis), fever
• Symptoms resolve after stopping the drug — often over weeks to months — rather than persisting like true SLE
• Anti-dsDNA antibodies, prominent in true lupus, are often absent or low-titre in drug-induced disease, though this is not universal¹

The word “like” in lupus-like matters: drug-induced lupus from penicillamine is almost always reversible once the drug is withdrawn. True kidney involvement (nephritis at the level of true lupus) is rare. The prognosis once the drug is stopped is generally good.²

Do you have to switch medications?

For a lupus-like reaction — as opposed to a mild early rash or brief joint ache — the answer from the clinical guidelines is effectively yes: penicillamine should be stopped and not restarted.² This is a different situation from milder early hypersensitivity, where dose-reduction and desensitisation can sometimes work (see /post/ive-been-on-penicillamine-for-two-weeks-and-my-joints-hurt-a for more on that scenario). A lupus-like reaction represents a more significant immune activation, and rechallenge with penicillamine carries a high risk of reproducing the reaction — often more quickly and sometimes more severely.³

The EASL guidelines and the 2022 AASLD Practice Guidance both identify this class of reaction as an indication to switch to an alternative rather than attempt a restart.^{2 4}

Is restarting penicillamine ever an option?

In almost all cases: no. The clinical guidance is unambiguous that a confirmed lupus-like reaction to penicillamine is a contraindication to restarting the drug.² This is not overly cautious — it reflects the real risk of a more severe reaction on rechallenge and the fact that effective alternatives exist.

If someone has told you it might be possible to restart after a very low dose titration or a long washout period, get a second opinion from a Wilson disease specialist before proceeding. Some centres have experimented with rechallenge in exceptional circumstances, but this is not a standard approach and carries real risk.³

What comes next: switching to trientine

Trientine (triethylene tetramine) is the established alternative chelating agent for patients who cannot tolerate penicillamine, and it has been used in this role since the 1980s.⁵ It works by a different mechanism than penicillamine — binding copper in the gut and promoting urinary copper excretion — but achieves comparable copper removal in most patients. Crucially, patients who react to penicillamine do not typically cross-react to trientine: it is a chemically unrelated compound.

A comparison study of penicillamine and trientine in Wilson disease patients found that trientine produced equivalent biochemical outcomes with a more favourable side-effect profile overall.⁶ In the largest paediatric Wilson disease series comparing all three major treatment options, trientine showed comparable efficacy to penicillamine in copper-level control with fewer immune-related adverse events.⁷

What you should know about trientine:

• It requires the same attention to timing with food (taken away from meals) and copper-rich supplements as penicillamine
• It does not carry the same lupus, skin, or renal hypersensitivity profile
• It has its own potential side effects — notably sideroblastic anaemia and iron deficiency in a minority of patients — that your specialist will monitor for
• It is substantially more expensive than penicillamine in many countries, which can be a practical obstacle (see /post/i-live-outside-the-us-and-cannot-afford-trientine-is-there-a for access considerations)

What about zinc?

Zinc salt therapy (zinc acetate, zinc sulphate, or zinc gluconate) is a third option, though it works differently: it blocks intestinal copper absorption rather than chelating copper for urinary excretion. Zinc is effective as a maintenance therapy once copper levels are well controlled, and it is used as first-line therapy in some presentations (asymptomatic patients, post-liver transplant maintenance, pregnancy).⁴

However, for patients who were on penicillamine because they needed active copper reduction and have now had to stop it, zinc alone may not provide sufficient copper removal in the short term. Your specialist will assess whether your current copper burden requires continued chelation with trientine, or whether the switch to zinc is clinically safe for your stage of disease.

What happens to the lupus-like symptoms after stopping?

Most symptoms of drug-induced lupus from penicillamine resolve within weeks to months of stopping the drug — joint symptoms, fever, and rash typically improve first; ANA titres fall more slowly and may remain detectable for some time without being clinically relevant.¹ If symptoms persist beyond three to four months after stopping penicillamine, or if they are severe (serositis, significant systemic symptoms), your specialist may consider a short course of corticosteroids to help resolve the autoimmune activity.

You should not require long-term treatment for the lupus-like reaction itself in most cases. The goal is to stop the drug, manage the acute reaction, and get you established on an effective alternative.

Talking to your specialist

When you next see your Wilson disease team, the key questions to address are:

• What is the current state of your copper control? Stopping penicillamine needs to be bridged promptly.
• Is trientine available and accessible in your country or insurance plan?
• Is your degree of copper overload best addressed with trientine alone, or in combination with zinc?
• How will the lupus-like reaction itself be monitored and managed while it resolves?

A confirmed lupus-like reaction is one of the clearer-cut decision points in Wilson disease management: stop penicillamine, switch to trientine, and monitor the immune reaction as it resolves. The switch is well established, and most patients manage well on trientine long-term.

This article is for patient education only. A lupus-like reaction to penicillamine requires medical evaluation and management — this article cannot substitute for your specialist’s assessment of your specific situation.

References